VI Partners
Founded in 2001, VI Partners is the longest-established Venture Capital firm in Switzerland that specializes in financing early-stage Life Science and Technology companies.
-
Type of investor
VC -
Based in
Zug -
Number of investments
10+ -
Industry
biotech, cleantech, ICT, ICT (fintech), Interdisciplinary, medtech, micro / nanoVisit website of
VI Partners
Related News
10.03.2025 11:00
Vi Partners leads Kadoa’s funding round
18.09.2024 09:00
Vi Partners leads CHF 3m round for Almer Technologies
22.08.2024 09:00
FLOWIT sichert sich 4 Millionen Franken in überzeichneter Seed-Runde
24.06.2024 09:05
iOnctura closes EUR80 million Series B financing
29.12.2023 16:52
LeaseTeq raises CHF8 million to digitize leasing
03.03.2023 13:27
Oculis goes public on Nasdaq
24.01.2023 08:50
Acodis secures CHF 6 million
18.10.2022 17:00
Oculis to go public via SPAC
04.10.2022 16:33
Araris Biotech Closes $24 Million Financing Round
21.09.2022 15:00
Ledgy banks $22 million in Series B round
01.09.2022 16:52
Skribble scoops CHF 10 million to scaleup e-signature service
13.07.2022 17:05
USD 1 million for smart productivity calendar
27.04.2022 09:00
VI Partners leads Picterra’s $6.5M investment round
11.04.2022 13:40
Unique raises USD $6.4 million seed extension and acquires Ciara
24.02.2022 08:21
Growth funding round for Equippo
07.09.2021 14:01
Ledgy completes $10 million series A round
07.05.2021 14:06
Oculis closes US$57 million Series C financing
14.04.2021 09:44
Medical device company CeQur raises $115 million
14.07.2020 12:01
iOnctura extends series A round to €20 million
13.05.2020 10:36
VI Partners launches a new early-stage venture fund for Switzerland
24.01.2020 15:02
Geneva-based biopharma startup raises €15 million
06.09.2019 10:05
Xeltis’ closes €10.5 million Series D financing
20.08.2019 09:00
Araris obtains CHF 2.5 million after only six months of existence
30.07.2019 15:05
SMART VALOR launches its digital asset platform
19.07.2019 13:30
Gamaya raises CHF12 million in the Series B round
03.07.2019 15:00
L.E.S.S. raises CHF 14 million to enter the automotive market
31.05.2019 12:37
Digital Health Startup Altoida Raises $6.3M Series A
12.12.2018 12:30
Nexthink Raises $85 Million
03.12.2018 10:50
Eine Million Euro für Ledgy
12.11.2018 10:05
AMAL Therapeutics finalises CHF 33 million Series B round
15.11.2017 08:29
Xeltis Closes €45 Million in Series C Financing
05.09.2017 11:45
AMAL Therapeutics raises CHF 8.8 million in Series B round
10.01.2017 08:19
13.5 Millionen Franken für Advanon
27.10.2016 08:56
Inositec Secures CHF1.4 million in Seed Financing
23.05.2016 09:30
Gamaya closes CHF 3.2 Million Series A financing round
30.03.2016 09:24
Amal Therapeutics raises CHF 3 million in a Series A financing round
17.12.2015 09:30
Xeltis acquires additional €3M in series B financing
16.11.2015 09:15
KUROS announces second closing of a CHF 20 million financing round
23.10.2015 13:23
Sequana Medical AG raises CHF 9 million
02.09.2015 09:18
CeQur Announces $100 Million Series C Financing
19.08.2015 10:09
Kuros announces closing of a CHF 15m financing round
28.04.2015 09:34
L .E.S.S. SA closes CHF 3 .0 million Series A financing
07.01.2015 08:56
Genkyotex Raises CHF 20 Million and Considers IPO
02.12.2014 16:24
Xeltis closes CHF 32 million Series B financing
27.11.2013 15:39
Endosense closes CHF 37.4 million series C round
06.11.2013 12:24
Delenex Therapeutics closes CHF 7.3 Million Series A3 Financing
31.05.2012 15:50